All posts by Steven Novella

Founder and currently Executive Editor of Science-Based Medicine Steven Novella, MD is an academic clinical neurologist at the Yale University School of Medicine. He is also the host and producer of the popular weekly science podcast, The Skeptics’ Guide to the Universe, and the author of the NeuroLogicaBlog, a daily blog that covers news and issues in neuroscience, but also general science, scientific skepticism, philosophy of science, critical thinking, and the intersection of science with the media and society. Dr. Novella also has produced two courses with The Great Courses, and published a book on critical thinking - also called The Skeptics Guide to the Universe.

Don’t Forget About the Flu

We are heading into a bad flu season. Get vaccinated.

/ November 16, 2022

Study – For Lowering Cholesterol, Statins Work, Supplements Don’t

A study comparing a statin drug and six common supplements to placebo shows that only the drug lowers bad cholesterol.

/ November 9, 2022

Risk of Myocarditis Following COVID-19 Vaccine

Risk of myocarditis following mRNA vaccines is real but tiny, and far outweighed by the benefit of vaccines.

/ November 2, 2022

The Subvariants Are Coming

A wave of Omicron subvariants are coming. So get vaccinated.

/ October 26, 2022

Sleep Duration and Health

Poor sleep is a genuine concern, but the results of a new cohort study are complex to interpret.

/ October 19, 2022

Burden of Proof Studies and Health Risk

A new way of presenting knowledge about health risks highlights the ambiguity of the evidence and the importance of basic health behaviors.

/ October 12, 2022

FDA Approves Controversial ALS Drug – Relyvrio

A close look a the FDA approval of Relyvrio.

/ October 5, 2022

Using Viruses to Treat Cancer

Engineering viruses to target cancer cells is an emerging and promising avenue for cancer treatment.

/ September 28, 2022

Study of Multivitamin Use and Memory

Routine multivitamins are likely not the best strategy for cognitive effects.

/ September 21, 2022

A New Malaria Vaccine

A second anti-malarial vaccine in just two years could be a game-changer for this deadly disease.

/ September 14, 2022